PhD, MD. V.A. Yakovenko.
Medical center “Oberig” Universal hospital”, Kiev, Ukraine. State Scientific Institution «Scientific-practical center of prophylactic and clinical medicine» of Administrative Department, Kiev, Ukraine. National Medical University named after. O.O. Bogomolets
Barrett’s esophagus is a potentially dangerous complication of GERD. Depending on the histological type of metastasis epithelium of the distal part of the esophagus, the risk of developing adenocarcinoma in the Barrett’s esophagus ranges from 0.5% to 30% per year. A modern, non-invasive way of treating Barrett’s esophagus is endoscopic radiofrequency ablation of parts of the cylindrical metaplasia of the distal part of the esophagus. Aim. The experience of the first in Ukraine application of a circular cylinder for endoscopic radiofrequency ablation at Barrett’s esophagus is presented.
Materials and methods. A 43-year-old patient has been diagnosed with a long segment of Barrett’s esophagus, 10 cm long. Morphological diagnosis: specialized intestinal metaplasia. An endoscopic radiofrequency ablationwas performed by circular balloon. For general anesthesia.
Results The patient is well tolerated by the ablation procedure. Any complaints were missing. In the postoperative period prescribed a mode of limiting heavy physical activity, a liquid diet during the week, antisecretory therapy. The patient is discharged from the hospital on the day after the operation in a satisfactory condition.
Conclusions The first in Ukraine endoscopic radiofrequency ablation of the Barrett esophagus is described with the help of a circular balloon. The described method of treatment can be an operation of choice in this group of patients, is an effective and safe method of treatment, well tolerated by patients, not accompanied by a change in the quality of life of patients. Further research is needed to attract more patients, which can be difficult due to the rarity of the pathology.
Key Words: Barrett’s esophagus, endoscopic treatment, endoscopic radiofrequency ablation, antisecretorytherapy, gastroesophageal reflux disease, adenocarcinoma of the esophagus.
|1. Korst RJ, Lee BE. The use of radiofrequency ablation for patients with nondysplastic Barrett’s esophagus. J Thorac Cardiovasc Surg. 2012;143(4):992-993. https://doi.org/10.1016/j.jtcvs.2011.12.055.
|2. Martínek J , Akiyama J, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, George T. Current treatment options for esophageal diseases. Ann N Y Acad Sci. 2016. doi:10.1111/nyas.13146.
|3. Nayna L, Emma W, Vani K. Radiofrequency ablation for low-grade dysplasia in Barrett’s esophagus. Curr Opin Gastroenterol. 2016;32(4):294-301. DOI: 10.1097/MOG.0000000000000277.
|4. Stier MW, Konda VJ, Hart J, Waxman I. Post-ablation surveillance in Barrett’s esophagus: a review of the literature. World J Gastroenterol. 2016;22(17):4297-4306. https://doi.org/10.3748/wjg.v22.i17.4297.
|5. Veeramachaneni N. Radiofrequency ablation for nondysplastic Barrett’s esophagus: should we do it, because we can? J Thorac Cardiovasc Surg. 2011;142(5):1173-1174. https://doi.org/10.1016/j.jtcvs.2011.08.034.
|6. Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR, Chmielewski GW, Corbett FS, Camara DS, Lightdale CJ, Wolfsen H, Chang KJ, Overholt BF, Pruitt RE, Ertan A, Komanduri S, Infantolino A, Rothstein RI, Shaheen NJ. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett’s Esophagus. Gastroenterology. 2015 Dec;149(7):1752-1761.e1. doi: 10.1053/j.gastro.2015.08.048.